Shuangcheng Pharmaceutical
SZSE · 002693
Market Cap$3.8B
Revenue$288.5M
Employees448
Listed OnSZSE
Ticker002693
CEO / ExecMr. Jianming Li
HeadquartersHaikou
MarketMainland China
Websitewww.shuangchengmed.com
Overview
Hainan Shuangcheng Pharmaceuticals Co., Ltd. engages in research and development, production, and sale of pharmaceutical injections, solid preparations, and raw materials in China and internationally. The company offers products for oncology and immune, alimentary canal, heart and cerebral, and vessels and metabolism. It also provides Bivalirudin, Epitifibatide, and Thymalfaxin for injection; Pregabalin capsule; and Memantine Hydrochloride tablets and Pioglitazone tablets USP. Hainan Shuangcheng
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.